Raily Aesthetic Medicine International Holdings Limited

SEHK:2135 Voorraadrapport

Marktkapitalisatie: HK$82.4m

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Raily Aesthetic Medicine International Holdings Beheer

Beheer criteriumcontroles 3/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Jianliang Song

Algemeen directeur

CN¥933.0k

Totale compensatie

Percentage CEO-salaris96.5%
Dienstverband CEO2.8yrs
Eigendom CEOn/a
Management gemiddelde ambtstermijn3.4yrs
Gemiddelde ambtstermijn bestuur3.8yrs

Recente managementupdates

Recent updates

Raily Aesthetic Medicine International Holdings Limited (HKG:2135) Held Back By Insufficient Growth Even After Shares Climb 37%

Oct 02
Raily Aesthetic Medicine International Holdings Limited (HKG:2135) Held Back By Insufficient Growth Even After Shares Climb 37%

Benign Growth For Raily Aesthetic Medicine International Holdings Limited (HKG:2135) Underpins Its Share Price

Jul 22
Benign Growth For Raily Aesthetic Medicine International Holdings Limited (HKG:2135) Underpins Its Share Price

Revenues Working Against Raily Aesthetic Medicine International Holdings Limited's (HKG:2135) Share Price Following 47% Dive

Apr 22
Revenues Working Against Raily Aesthetic Medicine International Holdings Limited's (HKG:2135) Share Price Following 47% Dive

Raily Aesthetic Medicine International Holdings Limited (HKG:2135) Stock Rockets 39% As Investors Are Less Pessimistic Than Expected

Feb 07
Raily Aesthetic Medicine International Holdings Limited (HKG:2135) Stock Rockets 39% As Investors Are Less Pessimistic Than Expected

Raily Aesthetic Medicine International Holdings Limited's (HKG:2135) Popularity With Investors Is Under Threat From Overpricing

Dec 19
Raily Aesthetic Medicine International Holdings Limited's (HKG:2135) Popularity With Investors Is Under Threat From Overpricing

Raily Aesthetic Medicine International Holdings Limited (HKG:2135) Investors Are Less Pessimistic Than Expected

Aug 22
Raily Aesthetic Medicine International Holdings Limited (HKG:2135) Investors Are Less Pessimistic Than Expected

Statutory Profit Doesn't Reflect How Good Raily Aesthetic Medicine International Holdings' (HKG:2135) Earnings Are

Sep 17
Statutory Profit Doesn't Reflect How Good Raily Aesthetic Medicine International Holdings' (HKG:2135) Earnings Are

Analyse CEO-vergoeding

Hoe is Jianliang Song's beloning veranderd ten opzichte van Raily Aesthetic Medicine International Holdings's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

-CN¥32m

Mar 31 2024n/an/a

-CN¥32m

Dec 31 2023CN¥933kCN¥900k

-CN¥32m

Sep 30 2023n/an/a

-CN¥26m

Jun 30 2023n/an/a

-CN¥20m

Mar 31 2023n/an/a

-CN¥18m

Dec 31 2022CN¥647kCN¥600k

-CN¥16m

Sep 30 2022n/an/a

-CN¥13m

Jun 30 2022n/an/a

-CN¥11m

Mar 31 2022n/an/a

-CN¥14m

Dec 31 2021CN¥1mCN¥1m

-CN¥18m

Sep 30 2021n/an/a

-CN¥3m

Jun 30 2021n/an/a

CN¥11m

Mar 31 2021n/an/a

CN¥8m

Dec 31 2020CN¥1mCN¥1m

CN¥4m

Sep 30 2020n/an/a

-CN¥25k

Jun 30 2020n/an/a

-CN¥4m

Mar 31 2020n/an/a

CN¥3m

Dec 31 2019CN¥2mCN¥2m

CN¥10m

Compensatie versus markt: De totale vergoeding ($USD 132.93K ) Jianliang } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de Hong Kong markt ($USD 233.84K ).

Compensatie versus inkomsten: De vergoeding van Jianliang is gestegen terwijl het bedrijf verliesgevend is.

CEO

Jianliang Song (68 yo)

2.8yrs

Tenure

CN¥933,000

Compensatie

Mr. Jianliang Song serves as an Executive Director at Raily Aesthetic Medicine International Holdings Limited and serves as its Chief Executive Officer since December 28, 2021. Mr. Song is responsible for...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Haishu Fu
Executive Chairman of the Board6.8yrsCN¥852.00k53.1%
HK$ 43.8m
Jianliang Song
CEO & Executive Director2.8yrsCN¥933.00kgeen gegevens
Chunxiu Zhang
Chief Financial Officerno dataCN¥433.00kgeen gegevens
Ying Wang
Executive Director2.8yrsCN¥558.00kgeen gegevens
Oi Fat Chan
Company Secretary3.9yrsgeen gegevensgeen gegevens

3.4yrs

Gemiddelde duur

47yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 2135 wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.4 jaar).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Haishu Fu
Executive Chairman of the Board6.8yrsCN¥852.00k53.1%
HK$ 43.8m
Jianliang Song
CEO & Executive Directorno dataCN¥933.00kgeen gegevens
Ying Wang
Executive Director2.8yrsCN¥558.00kgeen gegevens
Dequan Cao
Independent Non-Executive Director3.8yrsCN¥162.00kgeen gegevens
Xiaofen Yang
Independent Non-Executive Director3.8yrsCN¥162.00kgeen gegevens
Teng Liu
Independent Non-Executive Director3.8yrsCN¥162.00kgeen gegevens

3.8yrs

Gemiddelde duur

48.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 2135 wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.8 jaar).